25-OH Vitamin D and Interleukin-8: Emerging Biomarkers in Cutaneous Melanoma Development and Progression

<div>25-OH vitamin D3 serum level (ng mL<sup>−1</sup>) in melanoma patients (MM) compared to controls. Prevalence depicts the subgroups of low serum 25-OH vitamin D3 in the melanoma group of patients.</div>

Mediators of Inflammation

fig3

Figure 3

Figure 3: 25-OH Vitamin D and Interleukin-8: Emerging Biomarkers in Cutaneous Melanoma Development and Progression 